Horse chestnut – efficacy and safety in chronic venous insufficiency: an overview
Tóm tắt
Từ khóa
Tài liệu tham khảo
Annoni, 1979, Venotonic activity of escin on the human saphenous vein, Arzneimittel-Forsch., 29, 672
Arnould, 1996, Effect of aescine on hypoxia-induced activation of human endothelial cells, Eur. J. Pharmacol., 315, 227, 10.1016/S0014-2999(96)00645-0
Arnould, 1993, Increased PMN adherence on endothelial cells after hypoxia: involvement of PAF CD18/CD11b, and ICAM-1, Am. J. Physiol., 264, 1102, 10.1152/ajpcell.1993.264.5.C1102
Barnes, 2007, 363
Bisler, 1986, Wirkung von Roßkastaniensamenextrakt auf die transkapilläre Filtration bei chronisch venöser Insuffizienz, Deut. Med. Wochenschr., 111, 1321, 10.1055/s-2008-1068628
Bougelet, 1998, Effect of aescine on hypoxiainduced neutrophil adherence to umbilical vein endothelium, Eur. J. Pharmacol., 345, 89, 10.1016/S0014-2999(97)01616-6
Cebo, 1976, Własności farmakologiczne frakcji saponinowych otrzymanych z surowców krajowych: Saponaria officinalis Primula officinalis, Aesculs hippocastanum, Herba. Polon., 22, 154
Cesarone, 2001, Two-week topical treatment with Essaven gel in patients with diabetic microangiopathy – a placebo-controlled, randomized study, Angiology, 52, 43, 10.1177/000331970105200309
Cesarone, 2001, Microvascular changes in venous hypertension due to varicose veins after standardized application of Essaven gel – a placebo-controlled, randomized study, Angiology, 52, 11, 10.1177/000331970105200304
Damas, 1976, Sur làtionantioedeme de elèscine, Bull. Soc. Roy. Sci. Liège, 45, 436
De Sanctis, 2001, Treatment of superficial vein thrombosis with standardized application of Essaven gel – a placebo-controlled, randomized study, Angiology, 52, 57, 10.1177/000331970105200311
Diehm, 2001, Venostasin retard gegen Plazebo und Kompression bei Patienten mit CVI II/IIIA. Final Study Report. Klinge Pharma GmbH Munich, Germany. Reported in: Ottillinger B et al., BMC Cardiovasc. Disord., 1, 5, 10.1186/1471-2261-1-5
Diehm, 1996, Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency, Lancet, 347, 292, 10.1016/S0140-6736(96)90467-5
Diehm, 1992, Medical edema protection – clinical benefit in patients with chronic deep vein incompetence, VASA, 21, 188
EMEA (European Medicines Agency), 2012
Erdlen, 1989, Klinische Wirksamkeit von Venostasin retard im Doppelblindversuch, Med. Welt., 40, 994
Erler, 1991, Roßkastaniensamenextrakt bei der Therapie peripherer venöser Ödeme – ein klinischer Therapievergleich, Med. Welt, 42, 593
ESCOP Monographs, 2003
Facino, 1995, Anti-Elastase and anti-hyaluronidase activities of saponins and sapogenins from Hedera helix Aesculus hippocastanum and Ruscus aculeatus: factors contributing to their efficacy in the treatment of venous insufficiency, Arch. Pharm., 328, 720, 10.1002/ardp.19953281006
Felixsson, 2010, Horse chestnut extract contracts bovine vessels and affects human platelet aggregation through 5-HT2A receptors: an in vitro study, Phytother. Res., 24, 1297, 10.1002/ptr.3103
Friederich, 1978, Ein Beitrag zur Bewertung von intern wirksamen Venenpharmaka, Z. Hautkrankheiten., 53, 369
Girerg, 1961, The anti-edema properties of aescin, Arch. Int. Pharmakodyn., 133, 127
Guillaume, 1994, Veinotonic effect, vascular protection, antiinflammatory and free radical scavenging properties of horse chestnut extract, Arzneimittel-Forsch., 44, 25
Incandela, 2001, Microcirculation after standardized application of Essaven gel on normal skin – a placebo-controlled, randomized study, Angiology, 52, 5, 10.1177/000331970105200303
Kalbfleisch, 1989, Ödemprotektiva Äquipotente Dosierung – Roßkastaniensamenextrakt und O-β-Hydroxyethylrutoside im Vergleich, Therapiewoche, 39, 3703
Klemm, 1982, Strömungsgeschwindigkeit von Blut in varikösen Venen der unteren Extremitäten, Munchen. Med. Wochen, 124, 579
Koch, 2002, Comparative study of Venostasin and Pycnogenol in chronic venous insufficiency, Phytother. Res., 16, 1, 10.1002/ptr.1010
Liehn, 1972, A toxicological study of extractum Hippocastani semen (EHS), Panminerva Med., 14, 84
Lochs, 1974, Zur Beeinflussung des Venetonus durch Rosskastanienextrakte, Arzneimittel-Forsch., 24, 1347
Loew, 2000, Measurement of the bioavailability of aescin-containing extracts, Methods Find. Exp. Clin. Pharmacol., 22, 537, 10.1358/mf.2000.22.7.802264
Lohr, 1986, Ödempräventive Therapie bei chronischer Veneninsuffizienz mit Ödemneigung, Munchen. Med. Wochen., 128, 579
Matsuda, 1997, Antiinflammatory effects of escins Ia, Ib, IIa, and IIb from horse chestnut the seeds of Aesculus hippocastanum L., Bioorg. Med. Chem. Lett., 7, 1611, 10.1016/S0960-894X(97)00275-8
Michiels, 1993, Stimulation of prostaglandin synthesis by human endothelial cells exposed to hypoxia, Am. J. Physiol., 264, 866, 10.1152/ajpcell.1993.264.4.C866
Neiss, 1976, Zum Wirksamkeitsnachweis von Roßkastaniensamenextrakt beim varikösen Symptomenkomplex, Munchen. Med. Wochen., 118, 213
Panigati, 1992, The pharmacology of escin a saponin of Aesculus hippocastanum L. III. Pharmacokinetics and toxicology, Boll. Chim. Farm., 131, 320
Pauschinger, 1987, Klinisch experimentelle Untersuchungen zur Wirkung von Roßkastaniensamenextrakt auf die transkapilläre Filtration und das intravasale Volumen an Patienten mit chronisch venöser Insuffizienz, Phlebol. Proktol., 16, 57
Piechal, 2005, Kasztanowiec zwyczajny (Aesculus hippocastani) we współczesnej terapii, Przew. Lek., 4, 74
Pilz, 1990, Ödeme bei Venenerkrankungen, Med. Welt, 41, 1143
Pittler, 2012, Horse chestnut seed extract for chronic venous insufficiency, Cochrane Database Syst. Rev., 10.1002/14651858.CD003230.pub4
Raffetto, 2011, Ca(2+)-dependent contraction by the saponoside escin in rat vena cava: implications in venotonic treatment of varicose veins, J. Vasc. Surg., 54, 489, 10.1016/j.jvs.2011.01.043
Rehn, 1996, Vergleich der klinischen wirksamkeit und vertraglichkeit von oxerutin und Rosskastanien – extract bei patienten mit chronischer venoser Insuffizienz, Arzneimittel-Forsch., 46, 483
Rudofsky, 1986, Ödemprotektive Wirkung und klinische Wirksamkeit von Roßkastaniensamenextrakt im Doppeltblindversuch, Phlebol. Proktol., 15, 47
Sirtori, 2001, Aescin: pharmacology pharmacokinetics and therapeutic profile, Pharmacol. Res., 44, 183, 10.1006/phrs.2001.0847
Steiner, 1990, Venostasin retard in the management of venous problems during pregnancy, Phlebology, 5, 41, 10.1177/026835559000500109
Steiner, 1991, Ausmaß der ödemprotektiven Wirkung von Roßkastaniensamenextrakt, VASA, 20, 217
Sudoł-Szopińska, 2006, Wpływ czynników środowiskowych na rozwój przewlekłej niewydolności żylnej, Med. Pr., 57, 365